$1.56 0.04 (+2.89%)
11/27/2009 12:44 PM

DUSA Pharmaceuticals, Inc. (DUSA)

CAPS Rating: No stars

A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.

No one has written a Pitch for DUSA stock yet. Tell us why you think DUSA will outperform or underperform the S&P 500.

Featured Broker Partners